| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 9 |
| 1 | METFORMIN | 5 |
| 2 | ACETAMINOPHEN | 4 |
| 3 | METRONIDAZOLE | 4 |
| 4 | METRONIDAZOLE TOPICAL | 4 |
| 5 | PANTOPRAZOLE | 4 |
| 6 | SODIUM BICARBONATE | 4 |
| 7 | SODIUM BICARBONATE INJECTION, | 4 |
| 8 | SODIUM BICARBONATE, INJECTION | 4 |
| 9 | URSODIOL | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIUM ANTACID | 1 | 0.0023 |
| 1 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 2 | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | 1 | 0.0014 |
| 3 | RITLECITINIB | 2 | 0.0010 |
| 4 | FERRIC DERISOMALTOSE | 1 | 0.0007 |
| 5 | SELUMETINIB | 1 | 0.0006 |
| 6 | CLINDAMYCIN PHOSPHATE | 2 | 0.0004 |
| 7 | BECLOMETHASONE DIPROPIONATE HFA | 1 | 0.0003 |
| 8 | IOPAMIDOL | 1 | 0.0003 |
| 9 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 9 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 2 | GLP-1 Receptor Agonist [EPC] | 5 |
| 3 | Bile Acid [EPC] | 4 |
| 4 | Nitroimidazole Antimicrobial [EPC] | 4 |
| 5 | Corticosteroid [EPC] | 3 |
| 6 | GLP-2 Analog [EPC] | 3 |
| 7 | Opioid Agonist [EPC] | 3 |
| 8 | Amide Local Anesthetic [EPC] | 2 |
| 9 | Antiarrhythmic [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 1 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 2 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 3 | GLP-2 Analog [EPC] | 3 | 0.0002 |
| 4 | Bile Acid [EPC] | 4 | 0.0002 |
| 5 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 6 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 7 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 4 | 0.0001 |
| 9 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |